Sophia Genetics SA (SOPH) Social Stream



Sophia Genetics SA (SOPH): $4.17

0.05 (+1.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SOPHiA GENETICS SA (SOPH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SOPH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-16 3 $24 $23 $23.5 $8.38 180.43%
2021-11-11 3 $23 $23 $23 $8.38 174.46%
2022-02-15 3 $23 $18 $20.5 $8.38 144.63%
2022-03-17 3 $40.5 $17 $25.166 $8.38 200.31%

The Trend in the Analyst Price Target


Over the past 126 days, SOPH's average price target has gone up $2.17.

SOPH reports an average of 50.04% for its upside potential over the past 29 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-04 NA 24.0 22 23.000 19.46 18.19%
2021-09-09 NA 24.0 22 23.000 17.42 32.03%
2021-09-20 3 24.0 22 23.000 17.92 28.35%
2021-11-11 3 23.0 23 23.000 15.57 47.72%
2022-03-17 3 40.5 17 25.166 8.65 190.94%

SOPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 2 1 0 0 0 3

The Trend in the Broker Recommendations


Over the past 28 days, SOPH's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SOPH as an investment opportunity.

  • In the context of all US stocks, SOPHiA GENETICS SA's number of analysts covering the stock is greater than 44.6% of them.
  • SOPHiA GENETICS SA's variance in analysts' estimates is lower than -27.15% of all US stocks.
  • SOPH has a higher upside potential (average analyst target price relative to current price) than 345.62% of Technology stocks.
  • SOPHiA GENETICS SA's average analyst price target is higher than 91.05% of Technology stocks.

Stocks similar to SOPHiA GENETICS SA in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SLDB, SABS, and PTE.

Is SOPH a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3532 seconds.